Apyx Medical (NASDAQ:APYX) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
Apyx Medical (NASDAQ:APYX) is now covered by analysts at Roth Capital. They set a "buy" rating on the stock.
Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea
Apyx Medical Corporation Announces Pricing of $10 Million Public Offering of Common Stock
Apyx Medical Corporation Announces Proposed Public Offering of Common Stock [Yahoo! Finance]